Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2012

Open Access 01-12-2012 | Research article

The effect of obesity on spirometry tests among healthy non-smoking adults

Author: Mohammed Al Ghobain

Published in: BMC Pulmonary Medicine | Issue 1/2012

Login to get access

Abstract

Introduction

The effects of obesity on pulmonary functions have not been addressed previously among Saudi population. We aim to study the effects of obesity on spirometry tests among healthy non-smoking adults.

Methods

A cross sectional study conducted among volunteers healthy non-smoking adults Subjects. We divided the subjects into two groups according to their BMI. The first group consisted of non-obese subjects with BMI of 18 to 24.9 kg/m2 and the second group consisted of obese subjects with BMI of 30 kg/m2 and above. Subjects underwent spirometry tests according to American thoracic society standards with measurement of the following values: the forced vital capacity (FVC), forced expiratory volume in one second (FEV1), peak expiratory flow rate (PEF) and forced mid-expiratory flow (FEF25-75).

Results

The total subjects were 294 with a mean age of 32 years. There were 178 males and 116 females subjects. We found no significant differences in FEV1 (p value = 0.686), FVC (p value = 0.733), FEV1/FVC Ratio (p value = 0.197) and FEF25-75 (p value = 0.693) between the obese and non-obese subjects. However, there was significantly difference in PEF between the two groups (p value < 0.020).

Conclusion

Obesity does not have effect on the spirometry tests (except PEF) among health non-smoking adults. We recommend searching for alternative diagnosis in case of findings abnormal spirometry tests results among obese subjects.
Literature
1.
go back to reference World Health Organization: Obesity: Preventing and Managing the Global Epidemic. 1997, Geneva: WHO World Health Organization: Obesity: Preventing and Managing the Global Epidemic. 1997, Geneva: WHO
2.
go back to reference World Health Organization: Obesity: Preventing and Managing the Global Epidemic. 2004, Geneva: WHO World Health Organization: Obesity: Preventing and Managing the Global Epidemic. 2004, Geneva: WHO
3.
go back to reference Harik-Khan Raida I, Wise Robert A, Fleg Jerome L: The effect of gender on the relationship between body fat distribution and lung function. J Clin Epidemiol. 2001, 54 (4): 399-406. 10.1016/S0895-4356(00)00318-8.CrossRef Harik-Khan Raida I, Wise Robert A, Fleg Jerome L: The effect of gender on the relationship between body fat distribution and lung function. J Clin Epidemiol. 2001, 54 (4): 399-406. 10.1016/S0895-4356(00)00318-8.CrossRef
4.
go back to reference Mukhopadhvay S, Macleod KA, Ong TJ, Ogoston SA: Ethnic variation in childhood lung function may relate to preventable nutritional deficiency. Acta Pediatr. 2001, 90: 1299-1303. 10.1080/080352501317130362.CrossRef Mukhopadhvay S, Macleod KA, Ong TJ, Ogoston SA: Ethnic variation in childhood lung function may relate to preventable nutritional deficiency. Acta Pediatr. 2001, 90: 1299-1303. 10.1080/080352501317130362.CrossRef
5.
go back to reference Rossiter CE, Weill H: Ethnic differences in lung function: evidence for proportional differences. Int J Epidemiol. 1974, 3: 55-61. 10.1093/ije/3.1.55.CrossRefPubMed Rossiter CE, Weill H: Ethnic differences in lung function: evidence for proportional differences. Int J Epidemiol. 1974, 3: 55-61. 10.1093/ije/3.1.55.CrossRefPubMed
6.
go back to reference Yap WS, Chan CC, Chan SP, Wang YT: Ethnic differences in anthropometry among adult Singaporean Chinese, Malays and Indians, and their effects on lung volumes. Respir Med. 2001, 95: 297-304. 10.1053/rmed.2001.1038.CrossRefPubMed Yap WS, Chan CC, Chan SP, Wang YT: Ethnic differences in anthropometry among adult Singaporean Chinese, Malays and Indians, and their effects on lung volumes. Respir Med. 2001, 95: 297-304. 10.1053/rmed.2001.1038.CrossRefPubMed
7.
go back to reference Pérez-adillaa R, Valdiviab G, Muiñoc A, et al: Spirometric Reference Values in 5 Large Latin American Cities for Subjects Aged 40 Years or Over. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.CrossRef Pérez-adillaa R, Valdiviab G, Muiñoc A, et al: Spirometric Reference Values in 5 Large Latin American Cities for Subjects Aged 40 Years or Over. Eur Respir J. 2005, 26: 319-338. 10.1183/09031936.05.00034805.CrossRef
8.
go back to reference Fulambarker A, Copur AS, Javeri A, et al: Reference Values for Pulmonary Function in Asian Indians Living in the United States. Chest. 2004, 126: 1225-1233. 10.1378/chest.126.4.1225.CrossRefPubMed Fulambarker A, Copur AS, Javeri A, et al: Reference Values for Pulmonary Function in Asian Indians Living in the United States. Chest. 2004, 126: 1225-1233. 10.1378/chest.126.4.1225.CrossRefPubMed
9.
go back to reference Hnizdo E, Churchyard G, Dowdeswel R: Lung function prediction equations derived from healthy South African gold miners. Occup Environ Med. 2000, 57: 698-705. 10.1136/oem.57.10.698.CrossRefPubMedPubMedCentral Hnizdo E, Churchyard G, Dowdeswel R: Lung function prediction equations derived from healthy South African gold miners. Occup Environ Med. 2000, 57: 698-705. 10.1136/oem.57.10.698.CrossRefPubMedPubMedCentral
10.
go back to reference Faintuch J, Souza SAF, Valexi AC, Sant'ana AF, Gama-Rodrigues JJ: Pulmonary function and aerobic capacity in asymptomatic bariatric candidates with very severe morbid obesity. Rev Hosp Clin Fac Med S Paulo. 2004, 59: 181-186.CrossRefPubMed Faintuch J, Souza SAF, Valexi AC, Sant'ana AF, Gama-Rodrigues JJ: Pulmonary function and aerobic capacity in asymptomatic bariatric candidates with very severe morbid obesity. Rev Hosp Clin Fac Med S Paulo. 2004, 59: 181-186.CrossRefPubMed
11.
go back to reference Koenig SM: Pulmonary Complications of obesity. Am J Med Sci. 2001, 321: 249-279. 10.1097/00000441-200104000-00006.CrossRefPubMed Koenig SM: Pulmonary Complications of obesity. Am J Med Sci. 2001, 321: 249-279. 10.1097/00000441-200104000-00006.CrossRefPubMed
12.
go back to reference Rasslan Z, Junior RS, Stirbulov R, Fabbri RMA, Lima CAC: Evaluation of Pulmonary Function in Class I and II Obesity. J Bras Pneumol. 2004, 30: 508-514.CrossRef Rasslan Z, Junior RS, Stirbulov R, Fabbri RMA, Lima CAC: Evaluation of Pulmonary Function in Class I and II Obesity. J Bras Pneumol. 2004, 30: 508-514.CrossRef
13.
go back to reference Chery MS, et al: physiology of obesity and effects on lung function. J Appl Physiol. 2010, 108: 206-2011. 10.1152/japplphysiol.00694.2009.CrossRef Chery MS, et al: physiology of obesity and effects on lung function. J Appl Physiol. 2010, 108: 206-2011. 10.1152/japplphysiol.00694.2009.CrossRef
14.
go back to reference Carey IM, Cook DG, Strachan DP: The effects of adiposity and weight change on forced expiratory volume decline in a longitudinal study of adults. Int J Obes Relat Metab Disord. 1999, 23 (9): 979-985. 10.1038/sj.ijo.0801029.CrossRefPubMed Carey IM, Cook DG, Strachan DP: The effects of adiposity and weight change on forced expiratory volume decline in a longitudinal study of adults. Int J Obes Relat Metab Disord. 1999, 23 (9): 979-985. 10.1038/sj.ijo.0801029.CrossRefPubMed
15.
go back to reference Costa D, Barbalho MC, Miguel GP, Forti EM, Azevedo JL: The impact of obesity on pulmonary function in adult women. Clinics (Sao Paulo). 2008, 63 (6): 719-724. 10.1590/S1807-59322008000600002.CrossRef Costa D, Barbalho MC, Miguel GP, Forti EM, Azevedo JL: The impact of obesity on pulmonary function in adult women. Clinics (Sao Paulo). 2008, 63 (6): 719-724. 10.1590/S1807-59322008000600002.CrossRef
16.
go back to reference Jones RL, Nzekwu MM: The effects of body mass index on lung volumes. Chest. 2006, 130: 827-833. 10.1378/chest.130.3.827.CrossRefPubMed Jones RL, Nzekwu MM: The effects of body mass index on lung volumes. Chest. 2006, 130: 827-833. 10.1378/chest.130.3.827.CrossRefPubMed
17.
go back to reference Collins L, Hoberty PD, Walker JF, Fletcher EC, Peiris AN: The effect of body fat distribution on pulmonary function tests. Chest. 1995, 107: 1298-1302. 10.1378/chest.107.5.1298.CrossRefPubMed Collins L, Hoberty PD, Walker JF, Fletcher EC, Peiris AN: The effect of body fat distribution on pulmonary function tests. Chest. 1995, 107: 1298-1302. 10.1378/chest.107.5.1298.CrossRefPubMed
18.
go back to reference Unterborn J: Pulmonary Function Testing in Obesity, Pregnancy, and Extremes of Body Habitus. Clin Chest Med. 2001, 22 (4): 759-767. 10.1016/S0272-5231(05)70064-2.CrossRefPubMed Unterborn J: Pulmonary Function Testing in Obesity, Pregnancy, and Extremes of Body Habitus. Clin Chest Med. 2001, 22 (4): 759-767. 10.1016/S0272-5231(05)70064-2.CrossRefPubMed
19.
go back to reference Poulain M, Doucet M, Major GC, et al: The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ. 2006, 174: 1293-1299. 10.1503/cmaj.051299.CrossRefPubMedPubMedCentral Poulain M, Doucet M, Major GC, et al: The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies. CMAJ. 2006, 174: 1293-1299. 10.1503/cmaj.051299.CrossRefPubMedPubMedCentral
20.
go back to reference Sin DD, Jones RL, Man SF: Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med. 2002, 162: 1477-1481. 10.1001/archinte.162.13.1477.CrossRefPubMed Sin DD, Jones RL, Man SF: Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med. 2002, 162: 1477-1481. 10.1001/archinte.162.13.1477.CrossRefPubMed
Metadata
Title
The effect of obesity on spirometry tests among healthy non-smoking adults
Author
Mohammed Al Ghobain
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2012
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-12-10

Other articles of this Issue 1/2012

BMC Pulmonary Medicine 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.